AtriCure (ATRC) Tops Q1 EPS by 6c ; Offers Guidance
Tweet
Share
E-mailGet Alerts ATRC Hot Sheet
Price: $58.10 -1.73%
Revenue Growth %: +12.6%
Financial Fact:
Other: -32K
Today's EPS Names:
VIVO, OCCI, ALZN, More
Revenue Growth %: +12.6%
Financial Fact:
Other: -32K
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
AtriCure (NASDAQ: ATRC) reported Q1 EPS of $0.00, $0.06 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $141.2 million versus the consensus estimate of $139.54 million.
GUIDANCE:
AtriCure sees FY2026 EPS of $0.00-$0.04, versus the consensus of $0.14. AtriCure sees FY2026 revenue of $600-610 million, versus the consensus of $604.1 million.
For earnings history and earnings-related data on AtriCure (ATRC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- U.S. and Denmark close in on a Greenland deal - Reuters
- Leidos wins $85m Air Force contract for aerospace design
- Axion Minerals plans flow-through private placement of up to $440K
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
